πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 51 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10391097

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363244

Compositions comprising metformin and a glucokinase activator

VTV THERAPEUTICS LLC Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10363241

Substituted imidazole derivatives and methods of use thereof

VTV THERAPEUTICS LLC Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10364233

Piperidine derivative and methods of use thereof

VTV THERAPEUTICS LLC Β· Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10287284

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10172840

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions there

VTV THERAPEUTICS LLC Β· Granted Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10085990

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10064846

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC Β· Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10030011

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use t

VTV THERAPEUTICS LLC Β· Granted Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10004782

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968613

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I m

VTV THERAPEUTICS LLC Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9855274

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9855251

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9833457

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9717710

Treatment of mild and moderate Alzheimer's disease

VTV THERAPEUTICS LLC Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707239

Compounds that modulate oxidative stress

VTV THERAPEUTICS LLC Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687489

Tricyclic compounds as modulators of TNF-Ξ± synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9663481

Phenoxy acetic acids and phenyl propionic acids as PPARΞ΄ agonists

VTV THERAPEUTICS LLC Β· Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9598375

Substituted imidazole derivatives and methods of use thereof

VTV THERAPEUTICS LLC Β· Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487493

Use of a PPAR-delta agonist for treating muscle atrophy

VTV THERAPEUTICS LLC Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9447468

Compounds that modulate oxidative stress

VTV THERAPEUTICS LLC Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9393245

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9359313

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9198901

Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical

VTV THERAPEUTICS LLC Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted